Analysis of the inhibition of N-nitroso-dimethylamine activation in the liver by N-nitro-dimethylamine using a new non-linear statistical method

被引:5
作者
Frei, E
Gilberg, F
Schröder, M
Breuer, A
Edler, L
Wiessler, M
机构
[1] German Canc Res Ctr, Div Mol Toxicol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, D-69120 Heidelberg, Germany
关键词
D O I
10.1093/carcin/20.3.459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N-nitro-dimethylamine (NTDMA) is carcinogenic to rats: it induces nasal cavity tumours, It can be demethylated to N-nitromethylamine and formaldehyde and reduced to N-nitroso-dimethylamine (NDMA): a potent liver carcinogen and also of the nasal cavity if activation in the liver is blocked. To explain the mechanism of NTDMA carcinogenicity we compared its demethylation with that of NDMA in liver microsomes from female and male rats, untreated, fasted or treated with ethanol to induce cytochrome P450 2E1 (CYP2E1), Kinetic parameters were analysed by nonlinear statistical methods, which yielded unbiased parameter estimates for the calculated K-m and V-max values. K-m for both compounds was very similar in females (24-47 mu M) whereas V-max for NTDMA was consistently higher than for NDMA as substrate: 1.07-4.70 nmol formaldehyde/mg microsomal protein x min and 0.52-2.76 nmol, respectively. In liver microsomes from induced male rats NTDMA was found to be a much more effective inhibitor of NDMA activation (K-EI 39.6-73.6 mu M) than NDMA of NTDMA demethylation (K-EI 224-286 mu M). Nasal microsomes can demethylate both NDMA and NTDMA but the kinetics are vastly different. NTDMA is demethylated at a linear rate and similar to 10-fold more effectively than NDMA, The mechanism of carcinogenicity of ingested NTDMA, we propose, is a partial reduction to NDMA in the liver and inhibition of NDMA activation in the liver by residual NTDMA, which enables NDMA to reach the nasal mucosa where it is activated to DNA-alkylating species and the observed tumours are formed.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 21 条
[1]   CYTOCHROME-P450 2A OF NASAL EPITHELIUM - REGULATION AND ROLE IN CARCINOGEN METABOLISM [J].
BEREZIAT, JC ;
RAFFALLI, F ;
SCHMEZER, P ;
FREI, E ;
GENESTE, O ;
LANG, MA .
MOLECULAR CARCINOGENESIS, 1995, 14 (02) :130-139
[2]   AN ANALYSIS OF TRANSFORMATIONS [J].
BOX, GEP ;
COX, DR .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1964, 26 (02) :211-252
[3]   SYNTHESIS OF [C-14] LABELED N-NITRO METHYLAMINE AND N-NITRO DIMETHYLAMINE [J].
BRAUN, H ;
PLESCH, W ;
FREI, E ;
HASSEL, M ;
WIESSLER, M .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1989, 27 (06) :635-640
[4]   Formaldehyde mechanistic data and risk assessment: Endogenous protection from DNA adduct formation [J].
Conaway, CC ;
Whysner, J ;
Verna, LK ;
Williams, GM .
PHARMACOLOGY & THERAPEUTICS, 1996, 71 (1-2) :29-55
[5]   REDUCED GLUTATHIONE INHIBITS THE ALKYLATION BY N-NITROSODIMETHYLAMINE OF LIVER DNA INVIVO AND MICROSOMAL FRACTION INVITRO [J].
FREI, E ;
BERTRAM, B ;
WIESSLER, M .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 55 (1-2) :123-137
[6]  
FREI E, 1991, IARC SCI PUBL, V105, P358
[7]  
FREI E, 1984, INT AGENCY RES CANCE, V57, P491
[8]   PHARMACOKINETICS OF N-NITRODIMETHYLAMINE AND N-NITROMETHYLAMINE IN THE RAT [J].
HASSEL, M ;
FREI, E ;
STREETER, AJ ;
WIESSLER, M .
CARCINOGENESIS, 1990, 11 (03) :357-360
[9]  
HONG JY, 1991, CANCER RES, V51, P1509
[10]  
HU Y, 1995, BIOCHEM PHARMACOL, V50, P155